Suono Bio

Revolutionizing targeted gastrointestinal treatments

Suono Bio was founded in 2017, is headquartered in Cambridge, United States, lists 11–50 employees, and has $8.8M in recorded funding across 3 rounds.

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$8.8M
Last Round
$8.5M Series AJul 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Suono Bio is a Foxborough, Massachusetts-based biotechnology company founded in 2017 as an MIT spinout that harnesses a proprietary ultrasound-based drug delivery platform to enable localized delivery of small molecules, biologics, nucleic acids, and gene therapies to the gastrointestinal tract without encapsulation. The platform, developed from 30 years of discoveries in MIT labs, can treat difficult-to-treat inflammatory and GI diseases with superior effectiveness compared to conventional systemic delivery. Backed by MIT's The Engine and Fujifilm, Suono Bio aims to revolutionize targeted GI therapeutics.

Summary

Suono Bio is a Biotech company based in Cambridge, United States, founded in 2017. It lists 11–50 employees. It has raised $8.8M in total across 3 rounds, most recently a $8.5M Series A round in Jul 2021. Investors include Axil Capital, Mizuho Securities Principal Investment and The Engine.

Funding History

Series ASeries AJul 2021
$8.5M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Suono Bio on Indexed.vc
<a href="https://indexed.vc/companies/suono-bio"><img src="https://indexed.vc/api/badge/company/suono-bio" alt="Suono Bio on Indexed.vc" width="260" height="76" /></a>